Status:
COMPLETED
Point-of-care Monitoring of Antibiotic Concentration in Blood With UV-VIS Absorption Spectroscopy
Lead Sponsor:
Uppsala University
Conditions:
Sepsis
Infection, Bacterial
Eligibility:
All Genders
18+ years
Brief Summary
This prospective clinical study will investigate if antibiotic concentrations in patients with severe infections can be monitored by the UV-VIS spectroscopy.
Detailed Description
Early and correct antibiotic treatment has a fundamental effect on survival in severe infections, and to prevent resistance development. However, it is unclear if this is achieved in severely ill pati...
Eligibility Criteria
Inclusion
- More than 18 years old
- Suspected infection where treatment with cefotaxime, piperacillin/tazobactam or meropenem is prescribed
Exclusion
- Pregnancy
- Intermittent haemodialysis
- Patient with limited treatment decision
Key Trial Info
Start Date :
August 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 10 2023
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT04282785
Start Date
August 1 2022
End Date
August 10 2023
Last Update
June 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uppsala university hospital
Uppsala, Uppsala County, Sweden, 75185